Hyperhomocysteinemia but not MTHFR genotype is associated with young-onset essential hypertension

Journal of Human Hypertension

Volumn 17, Issue 5, 2003, Pages 361-364

  Garfunkel, V A M ^a   Porto, P I ^a   Garcia, S I ^a   Dieuzeide, G ^b   Kirszner, T ^c   Plotquin, Y ^c   Spataro, R J ^b   Gonzalez, C ^d   Pirola, Carlos J ^a  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^b CAIDEM ^*  (Argentina)

^c Hospital General de Agudos Dr Abel Zubizarreta   (Argentina)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTIHYPERTENSIVE AGENT; HOMOCYSTEINE;

ADOLESCENT; ADULT; AGE; AGED; AMINO ACID BLOOD LEVEL; CONTROLLED STUDY; DIET; DISEASE ASSOCIATION; ENZYME DEFICIENCY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; LETTER; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; STATISTICAL ANALYSIS;

BLOOD PRESSURE; CYSTATHIONINE BETA-SYNTHASE; DIASTOLE; GENETIC HETEROGENEITY; GENOTYPE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; SYSTOLE;

EID: 0037837604     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001549     Document Type: Letter

References (19)

1. McCully KS. Homocysteine and vascular disease. Nat Med 1996; 2: 386-389.
2. Mudd SH, Levy HL, Skovby F. Disorders of transulfuration. In: Scriver C, Beaudet AL, Sly WS, Valle D (eds). The Metabolic Basis of Inherited Disease. McGraw-Hill Book Co,: New York, 1989, pp 693-734.
3. Stabler SP et al. Elevation of total homocysteine in the serum of patients with cobalamin of folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 1998; 81: 466-474.
4. Frosst P et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
5. Perry IJ. Homocysteine, hypertension and stroke. J Hum Hypertens 1999; 13: 289-293.
6. Reports of the Second Task Force on Blood Pressure Control in Children. National Heart, Lung and Blood Institute, Bethesola, Maryland, 1987. Pediatrics 1987; 79: 1-25.
7. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes [see comments]. JAMA 1995; 274: 1049-1057.
8. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis. Circulation 1998; 98: 2520-2526.
9. Tsai JC et al. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci USA 1994; 91: 6369-6373.
10. El Kossi MM, Zakhary MM. Oxidative stress in the context of acute cerebrovascular stroke. Stroke 2000; 31: 1889-1892.
11. Kanani PM et al. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 1999; 100: 1161-1168.
12. Kitiyakara C, Gonin J, Massy Z, Wilcox CS. Non-traditional cardiovascular disease risk factors in end-stage renal disease: Oxidate stress and hyperhomocysteinemia. Curr Opin Nephrol Hypertens 2000; 9: 477-487.
13. Mujumdar VS, Hayden MR, Tyagi SC. Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells. J Cell Physiol 2000; 183: 28-36.
14. Kosmala W. [Endothelial dysfunction in hypertension - Clinical implications]. Pol Merkuriusz Lek 2002; 12: 333-335.
15. Groop L. Genetics of the metabolic syndrome. Br J Nutr 2000; 83: S39-S48.
16. Genest J. Plasma homocysteine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990; 16: 1114-1119.
17. Sorensen TK et al. Elevated second-trimester serum homocyst(e)ine levels and subsequent risk of preeclampsia. Gynecol Obstet Invest 1999; 48: 98-103.
18. Yoo JH, Chung CS, Kang SS. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis. Stroke 1998; 29: 2478-2483.
19. Collaboration HLT. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials. BMJ 1998; 316: 894-898.